IP Library Granted Patent US 8,416,398
Granted Patent B2
US 8,416,398 · App. 13/333,008 · Granted Apr 9, 2013

Method of differentiating between blood and control solutions containing a common analyte

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,416,398
App. No.
13/333,008
Granted
Apr 9, 2013
Kind
B2
Abstract

Glucose measured in blood samples is distinguished from glucose measured in the control solutions used to test the optical instruments which make such measurements. The control solutions contain a labeling substance recognized by the optical instrument to distinguish glucose measurements made of control solutions from those made of blood samples.

Claims (6)

1. A method of measuring the glucose in blood by an optical instrument, the method comprising the acts of testing the performance of the instrument by adding a control solution containing a known amount of glucose to a test strip adapted to react with the glucose and produce an optical response from an indicator and measuring the response, the control solution contains a labeling substance recognized by the optical instrument and distinguished from the response of the indicator, wherein the labeling substance has a peak absorbance of light that is distinguished from the absorbance of the indicator.

2. The method of claim 1 , wherein the labeling substance is indocyanine green.

3. The method of claim 2 , wherein the labeling substance is distinguished from a tetrazolium salt indicator.

4. The method of claim 1 , wherein the labeling substance has a characteristic response to excitation by a light-emitting diode in the optical instrument that is distinguishable from the response of the indicator.

5. The method of claim 1 , further comprising compiling the glucose measurements, the glucose measurements excluding control solution measurements.

6. The method of claim 1 , wherein the labeling substance is a dye adapted to be dissolved in the control solution.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 027661 FRAME: 0679. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 18, 2015
From: MARFURT, KAREN L.
To: BAYER HEALTHCARE LLC
Reel/Frame 037331/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2012
From: MARFURT, KAREN L.
To: BAYER HEALTHCARE, LLC
Reel/Frame 028288/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2012
From: MARFURT, KAREN L.
To: BAYER HEALTHCARE LLC
Reel/Frame 027661/0679 →